EGRX - Eagle Pharmaceuticals Inc
IEX Last Trade
5.13
-0.110 -2.144%
Share volume: 53,661
Last Updated: Fri 30 Aug 2024 09:59:52 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.24
-0.11
-2.10%
Fundamental analysis
26%
Profitability
29%
Dept financing
11%
Liquidity
31%
Performance
25%
Performance
5 Days
12.72%
1 Month
8.44%
3 Months
50.07%
6 Months
-18.02%
1 Year
-70.34%
2 Year
-84.76%
Key data
Stock price
$5.13
DAY RANGE
$5.12 - N/A
52 WEEK RANGE
$3.21 - $18.10
52 WEEK CHANGE
-$0.71
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
Company detail
CEO: Scott Tarriff
Region: US
Website: https://www.eagleus.com/
Employees: 153
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: https://www.eagleus.com/
Employees: 153
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
specialty pharmaceutical company
Recent news